VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 7.555 deferred stock units (DSUs) on Feb 6, 2026. The award is reported at a per-unit value of $25.20 for a total reported value of $190. This is an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-02-06; Filing date: 2026-02-10.
• Instrument: 7.555 Deferred Stock Units (derivative securities) @ $25.20; total reported value $190.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Footnotes: F1 — Each DSU represents the right to receive one share of common stock or the cash equivalent. F2 — DSUs will settle in cash or shares after termination of employment or in a specified future year per the Executive Deferral and Stock Match Plan.
• Filing timeliness: No late filing flag indicated in the provided data.

Context

• Deferred stock units are a form of compensation that convert to shares or cash later and do not reflect an immediate purchase or sale of company stock; they are routine for executive pay and don’t on their own signal a trading decision.